ORGANOGENESIS HOLDINGS INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $218.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-02-26
- ORGANOGENESIS HOLDINGS INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2021-12-31 was $299.00K.
- ORGANOGENESIS HOLDINGS INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2021-09-30 was $11.00K.
- ORGANOGENESIS HOLDINGS INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2021-06-30 was $10.00K.
- ORGANOGENESIS HOLDINGS INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2021-03-31 was $10.00K.
- ORGANOGENESIS HOLDINGS INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $218.00K, a 1881.82% increase from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $11.00K, a 97.80% decline from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $500.00K, a 23.76% increase from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was $404.00K, a 22.42% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 9 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $218.00K 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $11.00K 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $500.00K 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $404.00K 10-K · filed 2024-02-29 | |||
| 2021-12-31 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $310.00K derived: sum of 2 quarters · filed 2023-03-01 | $320.00K derived: sum of 3 quarters · filed 2023-03-01 | $330.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $21.00K derived: sum of 2 quarters · filed 2021-11-09 | $31.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $20.00K 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | $10.00K 10-Q · filed 2021-05-11 | |||
| 2020-12-31 | $317.00K 10-K · filed 2022-03-01 | |||
| 2019-12-31 | $269.00K 10-K · filed 2021-03-16 | |||
| 2018-12-31 | $209.00K 10-K · filed 2020-03-09 | |||
| 2017-12-31 | $159.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |